A study published days ago predicts that 25 million people worldwide will be living with the disease by 2050. The U.S., where a million people have the disease, reports 90,000 new diagnoses each year.

A study published days ago predicts that 25 million people worldwide will be living with the disease by 2050. The U.S., where a million people have the disease, reports 90,000 new diagnoses each year.

Starting today, people with Parkinson’s disease will have a new treatment option, thanks to U.S. Food and Drug Administration approval of groundbreaking new technology. The therapy, known as adaptive ...

NBC Bay Area’s Ian Cull takes a closer look in his video report above. Health Feb 25 FDA approves new Parkinson's Disease treatment Health Sep 24, 2024 What is Parkinson's disease?

"As Parkinson's disease progresses, levodopa treatment often becomes less effective at delivering consistent motor control in part due to GI dysmotility, variable absorption of oral medication ...

Posted: April 30, 2025 | Last updated: May 7, 2025 A new FDA-approved device, called a DBS device, claims to use adaptive deep brain stimulation to treat some with Parkinson's disease.

On a special episode (first released on May 29, 2025) of The Excerpt podcast: Parkinson’s is a disease that afflicts an estimated 90,000 Americans every year. Dr. Lorenz Studer and Dr. Viviane ...

While there is no cure for Parkinson’s disease, an upcoming experiment offers hope to the more than 10 million people living with the disorder that a breakthrough may be on the horizon.

Updated on Monday, March 24, 2025, at 4:46 p.m. A UCHealth patient made a bit of history Friday as the first person in the nation with Parkinson's disease to experience a treatment doctors are ...

Adaptive deep brain stimulation provides remarkable relief for 70-year-old conductor Rand Laycock, whose Parkinson's tremors impacted his musical career until a breakthrough in treatment.

Adaptive deep brain stimulation has virtually eliminated the most debilitating motor symptoms for some Parkinson’s patients and considerably improved their lives. At 40, Keith Krehbiel was a ...